Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122314383 | 12231438 | 3 | F | 200911 | 20160727 | 20160401 | 20160727 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-003500 | BRISTOL MYERS SQUIBB | 4.00 | DEC | M | Y | 0.00000 | 20160727 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122314383 | 12231438 | 1 | PS | STOCRIN | EFAVIRENZ | 1 | Oral | 600 MG, QD | Y | 21360 | 600 | MG | TABLET | QD | |||||
| 122314383 | 12231438 | 2 | SS | REYATAZ | ATAZANAVIR SULFATE | 1 | Oral | UNK | Y | 0 | CAPSULE, HARD | ||||||||
| 122314383 | 12231438 | 3 | SS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | 400 MG, BID | 0 | 400 | MG | BID | |||||||
| 122314383 | 12231438 | 4 | SS | LEXIVA | FOSAMPRENAVIR CALCIUM | 1 | Oral | 700 MG, BID | Y | 0 | 700 | MG | BID | ||||||
| 122314383 | 12231438 | 5 | SS | NORVIR | RITONAVIR | 1 | Oral | 100 MG, BID | Y | 0 | 100 | MG | BID | ||||||
| 122314383 | 12231438 | 6 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 122314383 | 12231438 | 7 | C | SULFAMETHOXAZOLE-TRIMETHOPRIM (SMZ) | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122314383 | 12231438 | 1 | HIV infection |
| 122314383 | 12231438 | 2 | HIV infection |
| 122314383 | 12231438 | 3 | HIV infection |
| 122314383 | 12231438 | 4 | HIV infection |
| 122314383 | 12231438 | 5 | HIV infection |
| 122314383 | 12231438 | 6 | HIV infection |
| 122314383 | 12231438 | 7 | Pneumocystis jirovecii pneumonia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122314383 | 12231438 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122314383 | 12231438 | Blood glucose increased | |
| 122314383 | 12231438 | Drug eruption | |
| 122314383 | 12231438 | Dyslipidaemia | |
| 122314383 | 12231438 | Liver disorder | |
| 122314383 | 12231438 | Type 1 diabetes mellitus | |
| 122314383 | 12231438 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122314383 | 12231438 | 1 | 200809 | 200911 | 0 | |
| 122314383 | 12231438 | 2 | 200911 | 201206 | 0 | |
| 122314383 | 12231438 | 3 | 201206 | 0 | ||
| 122314383 | 12231438 | 4 | 200911 | 201206 | 0 | |
| 122314383 | 12231438 | 5 | 200911 | 201206 | 0 | |
| 122314383 | 12231438 | 6 | 200809 | 0 |